Skip to main content

Table 1 Breast cancer gene expression profiling datasets analyzed in this study.

From: Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data

Reference Study summary Sample Size Microarray platforms Data download How dataset was used in this study
Van de Vijver et al. [3] Demonstrated that a 70-gene expression signature is a more powerful predictor for outcome than standard clinical and histological criteria in 295 primary breast cancer patients 295 Inkjet Oligo http://www.rii.com/publications/2002/nejm.html Initial unsupervised analysis to identify outcome associated pathways.
Wang et al. [8] Developed a 76-gene signature to predict distant metastasis using gene expression profiling data in 286 node negative primary breast cancer tumors 286 U133A http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2034 Initial unsupervised analysis to identify outcome associated pathways; Training dataset to build prognostic gene signature models.
Miller et al. [22] Identified a 32-gene signature from 251 primary breast cancers to distinguish p53-mutant and wild-type tumors and to predict prognosis. 251 U133A http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3494 Initial unsupervised analysis to identify outcome associated pathways; Independent dataset for validating the prognostic gene signature models.
Pawitan et al. [7] Identified a subset of 64 genes from gene expression profiles in 159 primary breast cancers that give an optimal separation of good and poor outcomes. 159 U133A http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1456 Initial unsupervised analysis to identify outcome associated pathways; Independent dataset for validating the prognostic gene signature models.
Bild et al. [21] Developed gene expression signatures for oncogenic pathways and demonstrated these signatures are predictive of clinical outcomes in lung, breast and ovarian cancers. 171 U95Av2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE3143 Initial unsupervised analysis to identify outcome associated pathways.